CIK 0000025743
- Non-accelerated filer
- Smaller reporting company
TherapeuticsMD, Inc.
Sign in to watch- Ticker
- TXMD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- Operating
- EIN
- 870233535
- Phone
- +1 561-961-1900
- Business address
- 951 YAMATO ROAD, SUITE 220, BOCA RATON, FL, 33431
- Former names
- AMHN, Inc., CROFF ENTERPRISES INC, CROFF OIL CO
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-11-03 | Collins Cooper C. Director | Grant or award · Restricted Stock Units | +8,500 | 8,500 | ||
| 2025-02-18 | Collins Cooper C. Director | Exercise or conversion | +8,500 | 60,516 | ||
| 2025-02-18 | Collins Cooper C. Director | Exercise or conversion · Restricted Stock Units | −8,500 | 0 | ||
| 2024-08-22 | Collins Cooper C. Director | Purchase | +4,094 | $1.73 | $7K | 52,016 |
| 2024-08-21 | Collins Cooper C. Director | Purchase | +1,200 | $1.70 | $2K | 47,922 |
| 2023-07-17 | Collins Cooper C. Director | Grant or award · Restricted Stock Units | +8,500 | 8,500 | ||
| 2022-09-29 | Collins Cooper C. Director | Grant or award · Restricted Stock Units | +5,000 | 5,000 | ||
| 2022-08-18 | Collins Cooper C. Director | Exercise or conversion | +1,984 | 46,722 | ||
| 2022-08-18 | Collins Cooper C. Director | Exercise or conversion · Restricted Stock Units | −1,984 | 0 | ||
| 2021-11-18 | Collins Cooper C. Director | Purchase | +1,000,000 | $0.58 | $579K | 2,236,864 |
| 2021-08-18 | Collins Cooper C. Director | Purchase | +900,000 | $0.72 | $648K | 1,236,864 |
| 2021-08-17 | Collins Cooper C. Director | Purchase | +100,000 | $0.77 | $77K | 336,864 |
| 2021-08-10 | Collins Cooper C. Director | Exercise or conversion | +96,864 | 236,864 | ||
| 2021-08-10 | Collins Cooper C. Director | Exercise or conversion · Restricted Stock Units | −96,864 | 0 | ||
| 2021-07-01 | Collins Cooper C. Director | Grant or award · Restricted Stock Units | +99,174 | 99,174 | ||
| 2020-06-18 | Collins Cooper C. Director | Grant or award · Restricted Stock Units | +96,864 | 96,864 | ||
| 2020-06-09 | Collins Cooper C. Director | Purchase | +47,500 | $1.45 | $69K | 140,000 |
| 2020-06-08 | Collins Cooper C. Director | Purchase | +26,500 | $1.45 | $38K | 92,500 |
| 2019-06-20 | Collins Cooper C. Director | Grant or award · Non-Qualified Stock Option (right to buy) | +75,000 | 75,000 | ||
| 2019-05-13 | Collins Cooper C. Director | Purchase | +30,000 | $3.33 | $100K | 66,000 |
Page 1 of 2 · 21 trades